Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence. The company's product pipeline focuses on treating opioid use disorder, alcohol use disorder, opiate overdose, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex.
Read More…
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone804-379-1090
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.01 billion
Profitability
Miscellaneous
Employees915
Next Earnings Date8/29/2019 (Estimated)
OptionableNot Optionable
INDIVIOR PLC/S (OTCMKTS:INVVY) Frequently Asked Questions
What is INDIVIOR PLC/S's stock symbol?
INDIVIOR PLC/S trades on the OTCMKTS under the ticker symbol "INVVY."
When is INDIVIOR PLC/S's next earnings date?
What guidance has INDIVIOR PLC/S issued on next quarter's earnings?
INDIVIOR PLC/S updated its FY 2019 earnings guidance on Wednesday, July, 31st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $670-720 million.
What is the consensus analysts' recommendation for INDIVIOR PLC/S?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for INDIVIOR PLC/S in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for INDIVIOR PLC/S.
Has INDIVIOR PLC/S been receiving favorable news coverage?
News stories about INVVY stock have trended positive this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. INDIVIOR PLC/S earned a daily sentiment score of 2.5 on InfoTrie's scale. They also gave news stories about the company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the near future. View News Stories for INDIVIOR PLC/S.
Who are some of INDIVIOR PLC/S's key competitors?
Some companies that are related to INDIVIOR PLC/S include Xencor (XNCR), Zai Lab (ZLAB), Zogenix (ZGNX), Emergent Biosolutions (EBS), Uniqure (QURE), Intercept Pharmaceuticals (ICPT), Akcea Therapeutics (AKCA), Cambrex (CBM), Portola Pharmaceuticals (PTLA), Biohaven Pharmaceutical (BHVN), Apellis Pharmaceuticals (APLS), Ligand Pharmaceuticals (LGND), Tricida (TCDA), Prestige Consumer Healthcare (PBH) and Eidos Therapeutics (EIDX).
What other stocks do shareholders of INDIVIOR PLC/S own?
Who are INDIVIOR PLC/S's key executives?
INDIVIOR PLC/S's management team includes the folowing people:
- Mr. Shaun Thaxter, CEO & Exec. Director
- Mr. Mark Crossley, CFO & Exec. Director
- Dr. Christian Heidbreder, Chief Scientific Officer
- Mr. Ingo Elfering, Chief Information & Innovation Officer
- Mr. Jason Thompson, VP of Investor Relations
How do I buy shares of INDIVIOR PLC/S?
Shares of INVVY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is INDIVIOR PLC/S's stock price today?
One share of INVVY stock can currently be purchased for approximately $3.66.
How big of a company is INDIVIOR PLC/S?
INDIVIOR PLC/S has a market capitalization of $533.12 million and generates $1.01 billion in revenue each year. The company earns $275 million in net income (profit) each year or $1.80 on an earnings per share basis. INDIVIOR PLC/S employs 915 workers across the globe.View Additional Information About INDIVIOR PLC/S.
What is INDIVIOR PLC/S's official website?
How can I contact INDIVIOR PLC/S?
INDIVIOR PLC/S's mailing address is 10710 Midlothian Turnpike, North Chesterfield VA, 23235. The company can be reached via phone at 804-379-1090 or via email at [email protected]
MarketBeat Community Rating for INDIVIOR PLC/S (OTCMKTS INVVY)
MarketBeat's community ratings are surveys of what our community members think about INDIVIOR PLC/S and other stocks. Vote "Outperform" if you believe INVVY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INVVY will underperform the S&P 500 over the long term. You may vote once every thirty days.
